Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.

Abstract:

OBJECTIVE:Many patients with early diabetes remain untreated. Our objectives were to identify clinical predictors of 1) worsening glycemic control and 2) medical treatment initiation in response to worsening glycemic control among patients with type 2 diabetes. RESEARCH DESIGN AND METHODS:We identified 5,804 type 2 diabetic patients seen at least twice between June 2005 and June 2006 within our 12-clinic primary care network. We examined predictors of diabetes progression (A1C >or=7% or initiation of hypoglycemic agent) over a 1-year follow-up period in 705 patients who had A1C <7% and were not on glucose-lowering medications at baseline. In the 200 patients in this group who progressed, we examined predictors of medical therapy initiation. RESULTS:In multivariate analyses, baseline A1C (P < 0.0001), younger age (P = 0.04), and weight gain (P = 0.03) were independent predictors of progression after adjusting for race, sex, and baseline HDL levels. Each decade of increasing age reduced the risk of progression by 15%. Each 1-lb increase in weight was associated with a 2% increased odds of progression. Likelihood of medication initiation among progressors decreased by 40% (P = 0.02) with every decade of age and decreased by 2.3% (P = 0.02) with each 1-mg/dl decrease in LDL level from baseline after adjusting for race, sex, and weight change. CONCLUSIONS:Among untreated primary care patients with type 2 diabetes and A1C <7%, younger patients and those with weight gain were more likely to have diabetes progression and should be the focus of aggressive diabetes management.

journal_name

Diabetes Care

journal_title

Diabetes care

authors

Pani LN,Nathan DM,Grant RW

doi

10.2337/dc07-1934

subject

Has Abstract

pub_date

2008-03-01 00:00:00

pages

386-90

issue

3

eissn

0149-5992

issn

1935-5548

pii

dc07-1934

journal_volume

31

pub_type

杂志文章
  • Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass.

    abstract:OBJECTIVE:Bariatric surgery may induce remission of type 2 diabetes in obese patients. However, estimates of remission rates reported in the literature range from 25 to 81%, contributing to the uncertainty patients and physicians both face as they assess treatment options. This analysis attempts to reconcile the seemin...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc16-0954

    authors: Isaman DJ,Rothberg AE,Herman WH

    更新日期:2016-12-01 00:00:00

  • Troponin T and pro-B-type natriuretic Peptide in fetuses of type 1 diabetic mothers.

    abstract:OBJECTIVE:Cardiomyopathy is noted in up to 40% of infants of diabetic mothers, and the exact mechanisms are unknown. The aim of this study was to determine whether fetal serum markers of cardiac function differ between normal and type 1 diabetic pregnancies and to examine the relationship between these markers and feta...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc09-0552

    authors: Russell NE,Higgins MF,Amaruso M,Foley M,McAuliffe FM

    更新日期:2009-11-01 00:00:00

  • No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial.

    abstract:OBJECTIVE:To describe the changes in serum levels of calcitonin in liraglutide- and placebo-treated patients in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results-A Long Term Evaluation (LEADER) trial over a 3.5-5-year period. RESEARCH DESIGN AND METHODS:Patients (n = 9,340) wi...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc17-1956

    authors: Hegedüs L,Sherman SI,Tuttle RM,von Scholten BJ,Rasmussen S,Karsbøl JD,Daniels GH,LEADER Publication Committee on behalf of the LEADER Trial Investigators.

    更新日期:2018-03-01 00:00:00

  • Effect of type 1 diabetes on carotid structure and function in adolescents and young adults: the SEARCH CVD study.

    abstract:OBJECTIVE:Type 1 diabetes mellitus causes increased carotid intima-media thickness (IMT) in adults. We evaluated IMT in young subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS:Participants with type 1 diabetes (N = 402) were matched to controls (N = 206) by age, sex, and race or ethnicity. Anthropometric and ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc12-2024

    authors: Urbina EM,Dabelea D,D'Agostino RB Jr,Shah AS,Dolan LM,Hamman RF,Daniels SR,Marcovina S,Wadwa RP

    更新日期:2013-09-01 00:00:00

  • Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM.

    abstract:OBJECTIVE:To provide information about possible subclinical damage of the cochlear outer hair cells (OHCs) by means of transiently evoked otoacoustic emissions (TEOAEs) and distortion-product otoacoustic emissions (DPOAEs) in subjects with IDDM. RESEARCH DESIGN AND METHODS:TEOAEs and DPOAEs were recorded in 47 IDDM pa...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.21.8.1317

    authors: Di Nardo W,Ghirlanda G,Paludetti G,Cercone S,Saponara C,Del Ninno M,Di Girolamo S,Magnani P,Di Leo MA

    更新日期:1998-08-01 00:00:00

  • Low-dose bedtime NPH insulin in treatment of secondary failure to glyburide.

    abstract::Secondary failure to oral hypoglycemic agents (OHAs) is a possible outcome for non-insulin-dependent diabetes mellitus (NIDDM) patients and poses a serious therapeutic problem. In this study, we evaluated the effect of adding a single bedtime low-dose NPH insulin injection to the previous ineffective sulfonylurea ther...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.12.8.582

    authors: Trischitta V,Italia S,Borzi V,Tribulato A,Mazzarino S,Squatrito S,Vigneri R

    更新日期:1989-09-01 00:00:00

  • Affinity sensor: a new technique for developing implantable sensors for glucose and other metabolites.

    abstract::We describe affinity sensors for monitoring various metabolites in blood plasma by optical means. The principle of detection is similar to that used in radioimmunoassays and is based on the competitive binding of a particular metabolite and a fluorescein-labeled analogue with receptor sites specific for the metabolite...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.5.3.245

    authors: Schultz JS,Mansouri S,Goldstein IJ

    更新日期:1982-05-01 00:00:00

  • Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial.

    abstract:OBJECTIVE:To evaluate safety and efficacy of DiaPep277 in preserving β-cell function in type 1 diabetic patients. RESEARCH DESIGN AND METHODS:DIA-AID 1 is a multinational, phase 3, balanced-randomized, double-blind, placebo-controlled, parallel-group clinical study. Newly diagnosed patients (N = 457, aged 16-45 years)...

    journal_title:Diabetes care

    pub_type: 杂志文章,收录出版

    doi:10.2337/dc13-1391

    authors: Raz I,Ziegler AG,Linn T,Schernthaner G,Bonnici F,Distiller LA,Giordano C,Giorgino F,de Vries L,Mauricio D,Procházka V,Wainstein J,Elias D,Avron A,Tamir M,Eren R,Peled D,Dagan S,Cohen IR,Pozzilli P,DIA-AID 1 Writin

    更新日期:2014-01-01 00:00:00

  • Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults.

    abstract:OBJECTIVE:Diabetes is a major predictor of death from heart disease and stroke; its impact on nonvascular mortality, including specific cancers, is less understood. We examined the association of diabetes with cause-specific mortality, including deaths from specific cancers. RESEARCH DESIGN AND METHODS:A prospective c...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc12-0002

    authors: Campbell PT,Newton CC,Patel AV,Jacobs EJ,Gapstur SM

    更新日期:2012-09-01 00:00:00

  • Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.

    abstract:OBJECTIVE:To determine the prevalence of IGT and diabetes and identify the occurrence of CVD and its risk factors. RESEARCH DESIGN AND METHODS:This study was a population-based, cross-sectional study of 110,660 residents, 25-74 yr of age of DaQing, Hei Long Jiang Province, China. RESULTS:Using 1985 WHO criteria, 577 ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.16.1.150

    authors: Pan XR,Hu YH,Li GW,Liu PA,Bennett PH,Howard BV

    更新日期:1993-01-01 00:00:00

  • Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes.

    abstract:OBJECTIVE:Diet is the cornerstone treatment of patients with gestational diabetes mellitus (GDM), but its role in maternal and newborn outcomes has been scarcely studied. The purpose of this study was to analyze the efficacy of dietary interventions on maternal or newborn outcomes in patients with GDM. RESEARCH DESIGN...

    journal_title:Diabetes care

    pub_type: 杂志文章,meta分析,评审

    doi:10.2337/dc14-1530

    authors: Viana LV,Gross JL,Azevedo MJ

    更新日期:2014-12-01 00:00:00

  • Glucocorticoid-induced ketoacidosis in gestational diabetes: sequela of the acute treatment of preterm labor. A case report.

    abstract::Pregnancy induces complex changes in energy metabolism, manifested clinically by insulin resistance, low fasting blood glucose levels, and proneness to ketosis. It is quite unusual for pregnant women who do not have type I diabetes to progress from ketosis to frank ketoacidosis, although this phenomenon is common in l...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.20.6.922

    authors: Bedalov A,Balasubramanyam A

    更新日期:1997-06-01 00:00:00

  • New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1).

    abstract:OBJECTIVE:To compare the efficacy and safety of new insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (≥42 units/day) plus mealtime insulin. RESEARCH DESIGN AND METHODS:EDITION 1 (NCT01499082) was a 6-month, multinational, open-label, parallel-...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2337/dc14-0991

    authors: Riddle MC,Bolli GB,Ziemen M,Muehlen-Bartmer I,Bizet F,Home PD,EDITION 1 Study Investigators.

    更新日期:2014-10-01 00:00:00

  • Dietary fat intake and cognitive decline in women with type 2 diabetes.

    abstract:OBJECTIVE:Individuals with type 2 diabetes have high risk of late-life cognitive impairment, yet little is known about strategies to modify risk. Targeting insulin resistance and vascular complications-both associated with cognitive decline-may be a productive approach. We investigated whether dietary fat, which modula...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc08-1741

    authors: Devore EE,Stampfer MJ,Breteler MM,Rosner B,Kang JH,Okereke O,Hu FB,Grodstein F

    更新日期:2009-04-01 00:00:00

  • High incidence of childhood-onset IDDM in Kuwait. Kuwait Study Group of Diabetes in Childhood.

    abstract:OBJECTIVE:To determine the incidence of insulin-dependent diabetes mellitus (IDDM) in children aged 0-14 years in Kuwait, as part of the World Health Organization Multinational Collaborative Study (DIAMOND), and to determine if the incidence rates have increased. RESEARCH DESIGN AND METHODS:All cases of IDDM diagnosed...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.18.7.923

    authors: Shaltout AA,Qabazard MA,Abdella NA,LaPorte RE,al Arouj M,Ben Nekhi A,Moussa MA,al Khawari MA

    更新日期:1995-07-01 00:00:00

  • Costs and consequences associated with newer medications for glycemic control in type 2 diabetes.

    abstract:OBJECTIVE:Newer medications offer more options for glycemic control in type 2 diabetes. However, they come at considerable costs. We undertook a health economic analysis to better understand the value of adding two newer medications (exenatide and sitagliptin) as second-line therapy to glycemic control strategies for p...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc09-1488

    authors: Sinha A,Rajan M,Hoerger T,Pogach L

    更新日期:2010-04-01 00:00:00

  • Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes.

    abstract:OBJECTIVE:The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria RESEARCH DESIGN AND METHODS:We analyzed the lipid profiles of patients with type 1 diabetes of > or = 20 years duration in 42 patients with albuminuria (28 microalbuminuri...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.29.01.06.dc05-1583

    authors: Molitch ME,Rupp D,Carnethon M

    更新日期:2006-01-01 00:00:00

  • Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria.

    abstract:OBJECTIVE:To investigate the influence of the insertion/deletion polymorphism of the ACE gene on the progression of early diabetic glomerulopathy in patients with and without antihypertensive treatment (AHT). RESEARCH DESIGN AND METHODS:There were 30 microalbuminuric patients with >5 years of type 1 diabetes who had r...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章

    doi:10.2337/diacare.23.4.544

    authors: Rudberg S,Rasmussen LM,Bangstad HJ,Osterby R

    更新日期:2000-04-01 00:00:00

  • Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.

    abstract:OBJECTIVE:Previous studies have provided inconclusive results on the role of uric acid (UA) in risk prediction. Here we aimed to improve the power and precision of the predictive value of UA for the risk of decline in kidney function, cardiovascular events (CVEs), and mortality in patients with type 1 diabetes (T1D). ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc18-2173

    authors: Pilemann-Lyberg S,Hansen TW,Tofte N,Winther SA,Theilade S,Ahluwalia TS,Rossing P

    更新日期:2019-06-01 00:00:00

  • Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

    abstract:OBJECTIVE:To determine the best autoantibody-based testing strategy for recruiting relatives for future intervention trials and to establish the role of islet cell antibodies (ICAs) within this strategy. RESEARCH DESIGN AND METHODS:ICAs, insulin autoantibodies (IAAs), GAD antibodies, and IA-2 antibodies were determine...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.22.11.1796

    authors: Bingley PJ,Williams AJ,Gale EA

    更新日期:1999-11-01 00:00:00

  • Motor vehicle accidents and IDDM.

    abstract::A case-control study examining the 1-yr motor vehicle accident experiences of 158 insulin-dependent diabetes mellitus (IDDM) cases and 158 nondiabetic siblings was undertaken to evaluate the risk of motor vehicle accidents among drivers with IDDM. In multivariate analyses the overall accident risk of the cases and con...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.11.9.701

    authors: Songer TJ,LaPorte RE,Dorman JS,Orchard TJ,Cruickshanks KJ,Becker DJ,Drash AL

    更新日期:1988-10-01 00:00:00

  • Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study.

    abstract:OBJECTIVE:To compare the efficacy and safety of glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS:In this prospective randomized controlled study, we randomly assigned patients with GDM at 13-33 weeks gestation and whose blood glucose...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc16-2307

    authors: Nachum Z,Zafran N,Salim R,Hissin N,Hasanein J,Gam Ze Letova Y,Suleiman A,Yefet E

    更新日期:2017-03-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.

    abstract:OBJECTIVE:To compare pharmacokinetics (PK) and pharmacodynamics (PD) of insulin glargine in type 2 diabetes mellitus (T2DM) after evening versus morning administration. RESEARCH DESIGN AND METHODS:Ten T2DM insulin-treated persons were studied during 24-h euglycemic glucose clamp, after glargine injection (0.4 units/kg...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc14-0649

    authors: Porcellati F,Lucidi P,Cioli P,Candeloro P,Marinelli Andreoli A,Marzotti S,Ambrogi M,Bolli GB,Fanelli CG

    更新日期:2015-03-01 00:00:00

  • Spanish diabetes self-management with and without automated telephone reinforcement: two randomized trials.

    abstract:OBJECTIVE:To determine 1) whether participants in the Spanish Diabetes Self-Management Program (SDSMP), when compared at 6 months to randomized control subjects, would demonstrate improvements in health status, health behaviors, and self-efficacy; and 2) whether SDSMP participants receiving monthly automated telephone ...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc07-1313

    authors: Lorig K,Ritter PL,Villa F,Piette JD

    更新日期:2008-03-01 00:00:00

  • Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study.

    abstract:OBJECTIVE:To evaluate the association between metformin use and anemia risk in type 2 diabetes, and the time-course for this, in a randomized controlled trial (RCT) and real-world population data. RESEARCH DESIGN AND METHODS:Anemia was defined as a hemoglobin measure of <11 g/dL. In the RCTs A Diabetes Outcome Progres...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc20-1104

    authors: Donnelly LA,Dennis JM,Coleman RL,Sattar N,Hattersley AT,Holman RR,Pearson ER

    更新日期:2020-10-01 00:00:00

  • Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients.

    abstract:OBJECTIVE:To study the effect of vitamin E supplementation on platelet hyperaggregability in type 1 diabetic patients. RESEARCH DESIGN AND METHODS:Written informed consent according to the Institutional Review Board on Human Experimentation guidelines was obtained from diabetic patients (n = 29) and their age-matched ...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diacare.21.9.1511

    authors: Jain SK,Krueger KS,McVie R,Jaramillo JJ,Palmer M,Smith T

    更新日期:1998-09-01 00:00:00

  • Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality?

    abstract:OBJECTIVE:Platelet hyperfunction is a typical feature of the prothrombotic state that frequently complicates the natural history of diabetes. In uremia, a bleeding diathesis is present, which principally involves the primary phase of hemostasis. Thus, in patients with uremia of diabetic origin, the infrequent coexisten...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.19.10.1062

    authors: Vicari AM,Taglietti MV,Pellegatta F,Spotti D,Melandri M,Galli L,Ronchi P,Folli F

    更新日期:1996-10-01 00:00:00

  • Comparing Type 2 Diabetes, Prediabetes, and Their Associated Risk Factors in Asian Indians in India and in the U.S.: The CARRS and MASALA Studies.

    abstract:OBJECTIVE:To assess the prevalence of diabetes and prediabetes and the associated risk factors in two Asian Indian populations living in different environments. RESEARCH DESIGN AND METHODS:We performed cross-sectional analyses, using representative samples of 2,305 Asian Indians aged 40-84 years living in Chennai, Ind...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc15-0032

    authors: Gujral UP,Narayan KM,Pradeepa RG,Deepa M,Ali MK,Anjana RM,Kandula NR,Mohan V,Kanaya AM

    更新日期:2015-07-01 00:00:00

  • Bacille Calmette-Guérin vaccination and incidence of IDDM in Montreal, Canada.

    abstract:OBJECTIVE:To describe the association between Bacille Calmette-Guérin (BCG) vaccination and IDDM development in two different case-control series (A and B) in Montreal. RESEARCH DESIGN AND METHODS:Case-control series A comprised 93 IDDM cases and 2,903 control subjects who participated in a community-based tuberculin ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.20.5.767

    authors: Parent ME,Siemiatycki J,Menzies R,Fritschi L,Colle E

    更新日期:1997-05-01 00:00:00

  • Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.

    abstract:OBJECTIVE:To provide evidence-based options on how to intensify basal insulin, we explored head-to-head prandial interventions in overweight patients with type 2 diabetes inadequately controlled on basal insulin glargine with or without 1-3 oral antidiabetic agents (OADs). RESEARCH DESIGN AND METHODS:Patients were ran...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc16-0014

    authors: Rosenstock J,Guerci B,Hanefeld M,Gentile S,Aronson R,Tinahones FJ,Roy-Duval C,Souhami E,Wardecki M,Ye J,Perfetti R,Heller S,GetGoal Duo-2 Trial Investigators.

    更新日期:2016-08-01 00:00:00